Literature DB >> 3763074

Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder.

I S Fraser, G McCarron, R Markham, T Resta, A Watts.   

Abstract

Fifty-five women with a convincing clinical history of menorrhagia associated with recognizable pelvic disease (40 women) or a confirmed coagulation disorder (15 women) were studied through one or more cycles with measurements of menstrual blood loss volume by a modified alkaline hematin method. Women with leiomyomata almost always exhibited large volumes of menstrual bleeding, which was invariably reduced by myomectomy and sometimes helped by mefenamic acid. Women with other pelvic disease such as endometriosis, adenomyosis, and myometrial hyperplasia also often exhibited genuine menorrhagia that responded to mefenamic acid, whereas others were found to have normal blood loss even when the history was convincing. Some women with coagulation disorders due to platelet dysfunction exhibited gross menorrhagia but others had blood loss within normal limits.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3763074

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  5 in total

1.  Platelet dysfunction and other hemostatic disorders in women with menorrhagia: the utility of whole blood lumi-aggregometer.

Authors:  O Meltem Akay; Fezan Mutlu; Zafer Gulbas
Journal:  Intern Emerg Med       Date:  2008-02-09       Impact factor: 3.397

Review 2.  Management of menorrhagia.

Authors:  A L Magos
Journal:  BMJ       Date:  1990-06-16

Review 3.  Menorrhagia. Current drug treatment concepts.

Authors:  M A van Eijkeren; G C Christiaens; P C Scholten; J J Sixma
Journal:  Drugs       Date:  1992-02       Impact factor: 9.546

Review 4.  Benefits and risks of pharmacological agents used for the treatment of menorrhagia.

Authors:  Samendra Nath Roy; Siladitya Bhattacharya
Journal:  Drug Saf       Date:  2004       Impact factor: 5.606

5.  Low birth weight is strongly associated with the risk of deep infiltrating endometriosis: results of a 743 case-control study.

Authors:  Bruno Borghese; Jeanne Sibiude; Pietro Santulli; Marie-Christine Lafay Pillet; Louis Marcellin; Ivo Brosens; Charles Chapron
Journal:  PLoS One       Date:  2015-02-13       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.